<?xml version='1.0' encoding='utf-8'?>
<document id="28890383"><sentence text="Interaction between rhein acyl glucuronide and methotrexate based on human organic anion transporters."><entity charOffset="47-59" id="DDI-PubMed.28890383.s1.e0" text="methotrexate" /></sentence><sentence text="Rhein, a major bioactive compound of many medicinal herbs and the prodrug of diacerein, is often used with low dose of methotrexate as drug combination to treat rheumatoid arthritis"><entity charOffset="77-86" id="DDI-PubMed.28890383.s2.e0" text="diacerein" /><entity charOffset="119-131" id="DDI-PubMed.28890383.s2.e1" text="methotrexate" /><pair ddi="false" e1="DDI-PubMed.28890383.s2.e0" e2="DDI-PubMed.28890383.s2.e0" /><pair ddi="false" e1="DDI-PubMed.28890383.s2.e0" e2="DDI-PubMed.28890383.s2.e1" /></sentence><sentence text=" In this study, potential drug-drug interaction between methotrexate and rhein was investigated based on organic anion transporters (OAT)"><entity charOffset="56-68" id="DDI-PubMed.28890383.s3.e0" text="methotrexate" /><entity charOffset="73-78" id="DDI-PubMed.28890383.s3.e1" text="rhein" /><pair ddi="false" e1="DDI-PubMed.28890383.s3.e0" e2="DDI-PubMed.28890383.s3.e0" /><pair ddi="false" e1="DDI-PubMed.28890383.s3.e0" e2="DDI-PubMed.28890383.s3.e1" /></sentence><sentence text=" Our study demonstrated that rhein acyl glucuronide (RAG), the major metabolite of rhein in the human blood circulation, significantly inhibited the uptake of p-aminohippurate in hOAT1 transfected cells with IC50 value of 691 nM and estrone sulfate uptake in hOAT3 transfected cells with IC50 value of 78"><entity charOffset="29-51" id="DDI-PubMed.28890383.s4.e0" text="rhein acyl glucuronide" /><entity charOffset="53-56" id="DDI-PubMed.28890383.s4.e1" text="RAG" /><entity charOffset="83-88" id="DDI-PubMed.28890383.s4.e2" text="rhein" /><entity charOffset="159-175" id="DDI-PubMed.28890383.s4.e3" text="p-aminohippurate" /><entity charOffset="233-248" id="DDI-PubMed.28890383.s4.e4" text="estrone sulfate" /><pair ddi="false" e1="DDI-PubMed.28890383.s4.e0" e2="DDI-PubMed.28890383.s4.e0" /><pair ddi="false" e1="DDI-PubMed.28890383.s4.e0" e2="DDI-PubMed.28890383.s4.e1" /><pair ddi="false" e1="DDI-PubMed.28890383.s4.e0" e2="DDI-PubMed.28890383.s4.e2" /><pair ddi="false" e1="DDI-PubMed.28890383.s4.e0" e2="DDI-PubMed.28890383.s4.e3" /><pair ddi="false" e1="DDI-PubMed.28890383.s4.e0" e2="DDI-PubMed.28890383.s4.e4" /><pair ddi="false" e1="DDI-PubMed.28890383.s4.e1" e2="DDI-PubMed.28890383.s4.e1" /><pair ddi="false" e1="DDI-PubMed.28890383.s4.e1" e2="DDI-PubMed.28890383.s4.e2" /><pair ddi="false" e1="DDI-PubMed.28890383.s4.e1" e2="DDI-PubMed.28890383.s4.e3" /><pair ddi="false" e1="DDI-PubMed.28890383.s4.e1" e2="DDI-PubMed.28890383.s4.e4" /><pair ddi="false" e1="DDI-PubMed.28890383.s4.e2" e2="DDI-PubMed.28890383.s4.e2" /><pair ddi="false" e1="DDI-PubMed.28890383.s4.e2" e2="DDI-PubMed.28890383.s4.e3" /><pair ddi="false" e1="DDI-PubMed.28890383.s4.e2" e2="DDI-PubMed.28890383.s4.e4" /><pair ddi="false" e1="DDI-PubMed.28890383.s4.e3" e2="DDI-PubMed.28890383.s4.e3" /><pair ddi="false" e1="DDI-PubMed.28890383.s4.e3" e2="DDI-PubMed.28890383.s4.e4" /></sentence><sentence text="5 nM" /><sentence text=" As the substrate of both hOAT1 and hOAT3, the methotrexate transport was significantly inhibited by RAG in hOAT1 transfected cells at 50 μM and hOAT3 transfected cells at 1 μM by 69% and 87%, respectively"><entity charOffset="47-59" id="DDI-PubMed.28890383.s6.e0" text="methotrexate" /><entity charOffset="101-112" id="DDI-PubMed.28890383.s6.e1" text="RAG" /><pair ddi="false" e1="DDI-PubMed.28890383.s6.e0" e2="DDI-PubMed.28890383.s6.e0" /><pair ddi="false" e1="DDI-PubMed.28890383.s6.e0" e2="DDI-PubMed.28890383.s6.e1" /></sentence><sentence text=" Further in vivo study showed that after co-administrated with RAG in rats the AUC0-24 values of methotrexate increased from 3109 to 5370 ng/mL*hr and the t1/2 was prolonged by 40"><entity charOffset="97-109" id="DDI-PubMed.28890383.s7.e0" text="methotrexate" /><entity charOffset="63-74" id="DDI-PubMed.28890383.s7.e1" text="RAG" /><pair ddi="false" e1="DDI-PubMed.28890383.s7.e1" e2="DDI-PubMed.28890383.s7.e1" /><pair ddi="false" e1="DDI-PubMed.28890383.s7.e1" e2="DDI-PubMed.28890383.s7.e0" /></sentence><sentence text="5% (from 7" /><sentence text="4 to 10" /><sentence text="4 h), demonstrating the inhibitory effect of RAG on methotrexate excretion"><entity charOffset="52-64" id="DDI-PubMed.28890383.s10.e0" text="methotrexate" /><entity charOffset="45-56" id="DDI-PubMed.28890383.s10.e1" text="RAG" /><pair ddi="false" e1="DDI-PubMed.28890383.s10.e1" e2="DDI-PubMed.28890383.s10.e1" /><pair ddi="false" e1="DDI-PubMed.28890383.s10.e1" e2="DDI-PubMed.28890383.s10.e0" /></sentence><sentence text=" In conclusion, rhein acyl glucuronide could significantly decrease the transport of methotrexate by both hOAT1 and hOAT3"><entity charOffset="16-38" id="DDI-PubMed.28890383.s11.e0" text="rhein acyl glucuronide" /><entity charOffset="85-97" id="DDI-PubMed.28890383.s11.e1" text="methotrexate" /><pair ddi="false" e1="DDI-PubMed.28890383.s11.e0" e2="DDI-PubMed.28890383.s11.e0" /><pair ddi="false" e1="DDI-PubMed.28890383.s11.e0" e2="DDI-PubMed.28890383.s11.e1" /></sentence><sentence text=" The combination use of rhein, diacerein or other rhein-containing herbs with methotrexate may cause obvious drug-drug interaction and require close monitoring for potential drug interaction in clinical practice"><entity charOffset="24-29" id="DDI-PubMed.28890383.s12.e0" text="rhein" /><entity charOffset="31-40" id="DDI-PubMed.28890383.s12.e1" text="diacerein" /><entity charOffset="50-55" id="DDI-PubMed.28890383.s12.e2" text="rhein" /><entity charOffset="78-90" id="DDI-PubMed.28890383.s12.e3" text="methotrexate" /><pair ddi="false" e1="DDI-PubMed.28890383.s12.e0" e2="DDI-PubMed.28890383.s12.e0" /><pair ddi="false" e1="DDI-PubMed.28890383.s12.e0" e2="DDI-PubMed.28890383.s12.e1" /><pair ddi="false" e1="DDI-PubMed.28890383.s12.e0" e2="DDI-PubMed.28890383.s12.e2" /><pair ddi="false" e1="DDI-PubMed.28890383.s12.e0" e2="DDI-PubMed.28890383.s12.e3" /><pair ddi="false" e1="DDI-PubMed.28890383.s12.e1" e2="DDI-PubMed.28890383.s12.e1" /><pair ddi="false" e1="DDI-PubMed.28890383.s12.e1" e2="DDI-PubMed.28890383.s12.e2" /><pair ddi="false" e1="DDI-PubMed.28890383.s12.e1" e2="DDI-PubMed.28890383.s12.e3" /><pair ddi="false" e1="DDI-PubMed.28890383.s12.e2" e2="DDI-PubMed.28890383.s12.e2" /><pair ddi="false" e1="DDI-PubMed.28890383.s12.e2" e2="DDI-PubMed.28890383.s12.e3" /></sentence><sentence text="" /></document>